Showing results (81-90 of 143) with videos related to
Sort By:
Pageof 15
Stem Cells (Dayton, Ohio)|August 14, 2012
ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targetsYuchun Luo, Katiuscia Dallaglio, Ying Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2019
Extended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in <i>BRAF</i>-Mutant MelanomaAntoni Ribas, Adil Daud, Anna C Pavlick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanomaNeil N Senzer, Howard L Kaufman, Thomas Amatruda, et al.Journal of Surgical Oncology|October 12, 2019
A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision makingChloe Friedman, Madison Lyon, Robert J Torphy, et al.Investigational New Drugs|September 25, 2007
A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanomaKarl D Lewis, William A Robinson, Michael J Millward, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)Jean-Jacques Grob, Rene Gonzalez, Nicole Basset-Seguin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanomaSanjiv S Agarwala, John Glaspy, Steven J O'Day, et al.The Lancet. Oncology|July 20, 2014
Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b studyAntoni Ribas, Rene Gonzalez, Anna Pavlick, et al.Dermatology and Therapy|September 24, 2021
Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629Brett G M Hughes, Rene Gonzalez Mendoza, Nicole Basset-Seguin, et al.Nature Medicine|June 8, 2019
Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patientsRyan J Sullivan, Omid Hamid, Rene Gonzalez, et al.Pageof 15